Research Team Discovers How Ebola Virus Enters, Replicates in a Host Cell
August 25, 2011 4:50 PM
comment(s) - last by
The team discovered a protein called Niemann-Pick C1 (NPC1), which they found was responsible for allowing Ebola virus to enter and replicate within cells
A team of scientists from different U.S. colleges and research institutes have discovered how and where Ebola virus enters a host cell, which has long been a mystery that deterred the creation of an effective vaccine.
Researchers from Whitehead Institute, Harvard Medical School, Albert Einstein College of Medicine and U.S. Army Medical Research Institute of Infectious Diseases have joined forces to better understand Ebola virus in order to eventually lead to the development of a vaccine that prevents
Ebola hemorrhagic fever (EHF)
Ebola virus is classified as a category A bioterrorism agent by the U.S. Centers for Disease Control and Prevention (CDC). While Ebola virus outbreaks are rare, they can cause EHF and are extremely dangerous to humans. Those with EHF have symptoms such as fever, diarrhea, vomiting, intense weakness, joint and muscle pain, and sometimes external or internal bleeding due to the disintegration of blood vessels.
While the symptoms of EHF can be treated, there is currently no vaccine to prevent it. According to the World Health Organization (WHO), there have been 1,850 EHF cases with 1,200 deaths since the virus was found in 1976.
"Right now, people make therapeutics to inactivate the pathogen itself," said Thijn Brummelkamp, former Whitehead Fellow and current leader at the Netherlands Cancer Institute (NKI). "But the problem is that pathogens can quickly change and escape detection and elimination by the immune system. Here we get a good idea of the host genes that are needed for the pathogen to enter the cell for replication. Perhaps by generating therapeutics against those host factors, we would have a more stable target for antiviral drugs."
The team of researchers discovered how Ebola virus gained entry into a host cell by using an unusual human cell line. All humans receive one copy of each chromosome from each parent, but cell lines have a single set instead with only one copy of each individual gene. Researchers wanted to use gene disruption, which "knocks out" a gene function in host cells one-by-one, to silence one copy of a gene.
Researchers used a technique that team member Jan Carette, of the Brummelkamp lab at Whitehead Institute, utilized while studying the cytolethal distending toxin (CDT) family. The CDT family secretes several pathogenic bacteria such as Escherichia coli, and each
has created different mutations of the CDT structure. Using a line of haploid cells, or KBM7 cells, which have only one copy of each chromosome and were isolated from a chronic myeloid leukemia patient, researchers could disrupt the expression of each gene while screening for mutants that had certain characteristics (specifically, those who could survive a lethal dose of the toxin).
While disrupting the normal structure of the gene, mutant KBM7 cells were exposed to the toxins and those that survived were studied. In the end, after studying the surviving cells' genomes, researchers were able to find ten human proteins used by CDT's during intoxication. Also, the host cells were adjusted for each CDT's target cell.
The research team utilized this same technique for Ebola virus using an unusual human cell line. Through the use of a harmless virus covered in the Ebola virus glycoprotein and the alteration of the haploid cells, the team discovered a protein called
Niemann-Pick C1 (NPC1)
, which they found was responsible for allowing Ebola virus to enter and replicate within cells. The mutations of this gene cause a type of Niemann-Pick disease.
The effects of the active Ebola virus were tested on mice who had a knocked-out copy of the NPC1 gene and mice with two functioning NPC1 genes. Those with two functioning NPC1 genes were affected by the virus very quickly while those with a knocked-out NPC1 gene were significantly protected.
"This is pretty unexpected," said Carette. "This might imply that genetic mutations in the NPC1 gene in humans could make some people resistant to this very deadly virus. And now that we know that NPC1 is an Ebola virus host factor, it provides a strong platform from which to start developing new antivirals."
was published in
This article is over a month old, voting and posting comments is disabled
RE: it could be used for good
8/25/2011 9:07:18 PM
How bout this one? $8.95 & eligible for FREE Super Saver Shipping
"I modded down, down, down, and the flames went higher." -- Sven Olsen
Veteran Researcher Dies After Accidental Infection of Plague Bacteria
September 21, 2009, 11:47 AM
Creationists are Mad About Google Doodle Depicting Evolution
November 24, 2015, 8:48 PM
DHS and TSA: Whoops, We Missed That 73 Airport Employees May be Terrorists
November 19, 2015, 2:16 PM
Star Wars Spinoff Film "Rogue One", Theme Park Attractions Announced
August 17, 2015, 12:20 PM
SpaceX Falcon 9's Seventh Supply Mission to ISS Ends w/ Fiery Stage 1 Explosion
June 28, 2015, 1:10 PM
Cool Science Video: Glowing Millipede Prowls the Nevada Desert
May 18, 2015, 12:00 PM
Newly Discovered Costa Rican Glass Frog is Kermit's Doppelgänger
April 22, 2015, 11:26 AM
Latest Blog Posts
Sceptre Airs 27", 120 Hz. 1080p Monitor/HDTV w/ 5 ms Response Time for $220
Dec 3, 2014, 10:32 PM
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
More Blog Posts
Copyright 2016 DailyTech LLC. -
Terms, Conditions & Privacy Information